Diamyd Medical Ab Stock Filter Stocks by Fundamentals
DMN Stock | EUR 0.82 0.01 1.23% |
Fundamental analysis of Diamyd Medical allows traders to better anticipate movements in Diamyd Medical's stock price by examining its financial health and performance throughout various phases of its business cycle.
Diamyd |
Did you try this?
Run ETFs Now
ETFsFind actively traded Exchange Traded Funds (ETF) from around the world |
All Next | Launch Module |
Diamyd Fundamentals
Return On Equity | -0.42 | |||
Return On Asset | -0.25 | |||
Current Valuation | 96.81 M | |||
Shares Outstanding | 76.93 M | |||
Shares Owned By Insiders | 35.22 % | |||
Shares Owned By Institutions | 0.26 % | |||
Price To Book | 5.52 X | |||
Price To Sales | 2,594 X | |||
Revenue | 454 K | |||
Gross Profit | (3.95 M) | |||
EBITDA | (98.88 M) | |||
Net Income | (103.52 M) | |||
Current Ratio | 5.83 X | |||
Book Value Per Share | 0.09 X | |||
Cash Flow From Operations | (93.22 M) | |||
Earnings Per Share | (0.11) X | |||
Target Price | 19.0 | |||
Number Of Employees | 20 | |||
Beta | 1.91 | |||
Market Capitalization | 99.6 M | |||
Total Asset | 236.52 M | |||
Net Asset | 236.52 M |
About Diamyd Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Diamyd Medical AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Diamyd Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Diamyd Medical AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Diamyd Stock
Diamyd Medical financial ratios help investors to determine whether Diamyd Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Diamyd with respect to the benefits of owning Diamyd Medical security.